IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 152 filers reported holding IMMUNITYBIO INC in Q1 2022. The put-call ratio across all filers is 2.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,801,912 | -13.7% | 14,675,687 | +42.0% | 0.00% | 0.0% |
| Q2 2023 | $28,726,578 | +90.5% | 10,333,301 | +24.7% | 0.00% | – |
| Q1 2023 | $15,080,444 | -64.0% | 8,285,958 | +0.4% | 0.00% | -100.0% |
| Q4 2022 | $41,854,098 | +4.2% | 8,255,246 | +2.2% | 0.00% | 0.0% |
| Q3 2022 | $40,155,000 | +43.5% | 8,079,541 | +7.4% | 0.00% | 0.0% |
| Q2 2022 | $27,983,000 | -30.3% | 7,522,377 | +5.1% | 0.00% | 0.0% |
| Q1 2022 | $40,146,000 | -7.5% | 7,156,146 | +0.2% | 0.00% | 0.0% |
| Q4 2021 | $43,403,000 | -36.6% | 7,138,537 | +1.5% | 0.00% | -50.0% |
| Q3 2021 | $68,484,000 | -13.7% | 7,031,258 | +26.5% | 0.00% | 0.0% |
| Q2 2021 | $79,398,000 | +30.7% | 5,560,023 | +117.2% | 0.00% | 0.0% |
| Q1 2021 | $60,761,000 | – | 2,559,391 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALLEN HOLDING INC /NY | 687,571 | $3,857,000 | 0.50% |
| ORACLE INVESTMENT MANAGEMENT INC | 400,013 | $2,244,000 | 0.44% |
| HARBOURVEST PARTNERS LLC | 335,709 | $1,883,000 | 0.38% |
| Winning Points Advisors, LLC | 60,126 | $339,000 | 0.26% |
| MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $541,000 | 0.19% |
| SHEETS SMITH WEALTH MANAGEMENT | 203,876 | $1,144,000 | 0.16% |
| Delphia (USA) Inc. | 25,504 | $143,000 | 0.11% |
| Clearwater Capital Advisors, LLC | 147,891 | $830,000 | 0.10% |
| Corton Capital Inc. | 36,843 | $207,000 | 0.09% |
| Virtus ETF Advisers LLC | 27,343 | $153,000 | 0.07% |